Northwest & Ethical Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,382
Closed -$76.8K 390
2017
Q1
$76.8K Sell
1,382
-400
-22% -$22.1K 0.01% 364
2016
Q4
$92.8K Buy
+1,782
New +$86K 0.01% 350

Other funds holding PBH

Northwest & Ethical Investments's PBH Position: Q2 2017 in Review

Northwest & Ethical Investments sold out of Prestige Consumer Healthcare (PBH) in Q2 2017, closing a stake of 1,382 shares — an estimated $76.8K sold.

Northwest & Ethical Investments first reported a position in PBH in Q4 2016 and held it in 2 quarters. The position peaked at $92.8K in Q4 2016. 232 funds tracked by Wall St. Rank hold PBH as of Q2 2017.

  • Northwest & Ethical Investments reported no remaining Prestige Consumer Healthcare position as of Q2 2017 after selling out during the quarter.
  • Northwest & Ethical Investments sold 1,382 Prestige Consumer Healthcare shares in Q2 2017, an estimated $76.8K.
  • Northwest & Ethical Investments first reported a position in Prestige Consumer Healthcare in Q4 2016 and held it in 2 quarters.
  • Northwest & Ethical Investments's Prestige Consumer Healthcare position peaked at $92.8K in Q4 2016.
  • 232 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2017.

Based on Northwest & Ethical Investments's 13F filing for Q2 2017, filed 8 Jul 2025.